Prof. Dr. med. Olaf G. Wilhelm is founder and Chief Executive Officer of Therawis Pharma GmbH and Therawis Diagnostics GmbH, Munich. He also was co-founder of Wilex Biotechnology GmbH and its Managing Director from October 1, 1997 until April 8, 2001, and has been Chief Executive Officer of WILEX AG since April 9, 2001 since the conversion of the company into a stock market corporation (Wilex AG). Prof. Wilhelm managed two company acquisitions, several international development and commercialization partnerships and listed Wilex AG on the public stock Exchange. In the year 2001, he was appointed Extraordinary Professor of Gynecology at the Technical University of Munich. From 1990 to 1997, he was employed as senior physician for Obstetrics and Gynecological Oncology at the Dept. Obstetrics & Gynecology (Frauenklinik) at the Medical School of the university hospital Klinikum rechts der Isar des Klinikums rechts der Isar) at the Technical University of Munich. While at the Technical University of Munich, Prof. Wilhelm was also a member of the Clinical Research Unit of the Frauenklinik. From 1987 to 1990, he worked as a scientist for Eli Lilly and Company, Indianapolis, Indiana/USA. Prof. Wilhelm received the Midwest Trainee Award of the American Federation for Clinical Research and has authored over 70 publications. He received his MD from the Technical University of Munich. In 2011, the Technical University of Munich awarded him the title “TUM Entrepreneur of Excellence”.